DCGO Stock Recent News

DocGo improved revenue in the second quarter. The company has added major contracts this year with EmblemHealth and Carnival Cruise Lines.

NEW YORK--(BUSINESS WIRE)--DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will present at three different investor conferences in September 2023. On Wednesday, September 13, 2023, at 3:35 Eastern Time, Mr. Capone will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City. A webcast of the event will be available on the investor relations sectio.

DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations Anthony Capone - Chief Executive Officer Lee Bienstock - President and Chief Operating Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Sarah James - Cantor Fitzgerald Matt Shea - Needham & Co Mike Latimore - Northland Capital Markets David Grossman - Stifel Kieran Ryan - Deutsche Bank Operator Good afternoon, and welcome to the DocGo Second Quarter 2023 Earnings Conference Call. At this time all participants are in listen-only mode.

DocGo Inc. (DCGO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 per share a year ago.

NEW YORK--(BUSINESS WIRE)--DocGo Inc., a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the second quarter ended June 30, 2023, after the markets close on Monday, August 7th. Management will host a conference call for analysts and investors at 5:00pm ET on that day. Conference call and webcast details: Monday, August 7th, 5:00pm EDT 1-877-407-0784 (U.S.) 1-201-689-8560 (international) Conference ID: 13739932 To acces.

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price target.  “At first glance, DocGo's 1Q results can be seen as mixed,” analysts wrote.

DocGo, Inc. (DGCO) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Mike Cole – Director-Investor Relations Anthony Capone – Chief Executive Officer Lee Bienstock – President and Chief Operating Officer Norm Rosenberg – Chief Financial Officer Conference Call Participants Mike Latimore – Northland Capital Markets Matt Shea – Needham John Pinney – Canaccord Genuity Craig Jones – Stifel Sarah James – Cantor Fitzgerald Jeb Terry – Aberdeen Investment Management Operator Greetings, and welcome to the DocGo First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

NEW YORK--(BUSINESS WIRE)--DocGo will announce Q1 2023 results on Monday, May 8th, via conference call.

We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low debt burden combined with ample liquidity put the company on a strong footing for future growth.